0.00Open0.05Pre Close0 Volume55 Open Interest2.50Strike Price0.00Turnover0.00%IV-70.59%PremiumJan 17, 2025Expiry Date6.17Intrinsic Value100Multiplier14DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma173.40Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Traws Pharma Stock Discussion
📊⚡️📊
Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval
Monday, 30th December at 8:00 am
Initial tranche of $20 Million extends cash runway into 1H26, subsequent tranche of up to $52.6 Million will provide for runway 3+ years enabling the company to reach both near-term and long-term value inflecting readouts
NEWTOWN, Pa., Dec. 30, 2024 /PRNewswir...
$Apple (AAPL.US)$
$Traws Pharma (TRAW.US)$
DO NOT WORRY, THIS IS SOMETHING THAT I CAN AFFORD. DO NOT TRY SOMETHING LIKE THIS UNLESS YOU CAN AFFORD IT. DO NOT RISK TOO MUCH AND USE STRATEGIES.
📊⚡️📊
No comment yet